Scientific Advisory Board

The purpose of the Scientific Advisory Board (SAB) is to provide advice and guidance to the Hydrocephalus Association staff and Board of Directors. SAB members are selected for their scientific knowledge and expertise in areas such as drug and device development. Their input informs strategic planning and guides the actions of the Hydrocephalus Association’s Research Department.

Yun Yung

Yun Yung, PhD

Chair, Scientific Advisory Board
CEO, Pomelo Biosciences, Inc
Assistant Professor
The Scintillon Research Institute

Matt Borzage

Matthew Thomas Borzage, PhD

Associate Professor of Research Pediatrics, Biomedical Engineering, Regulatory and Quality Sciences
University of Southern California

Daniel Donoho

Daniel Donoho, MD

Assistant Professor of Neurological Surgery and Pediatrics
George Washington University

Kevin King

Kevin King, MD, MSCS

Professor, Department of Neuroradiology
Barrow Neurological Institute

Scott Olson

R. Scott Olson, MBA

Commercialization Director
Office for Technology Commercialization
Wayne State University

Alejandro Rojas

Alejandro Rojas, PhD

Co-founder, Head of Biology
Verto Therapeutics

Michael Rogawski

Michael A. Rogawski, MD, PhD

Distinguished Professor of Neurology and Pharmacology
University of California, Davis

Jiwu Wang

Jiwu Wang, PhD

CEO, Allele Biotechnology and Pharmaceuticals, Inc.
President and Professor, The Scintillon Institute

Was this resource helpful?

Yes
No
Thanks for your feedback!